On-Demand Upstream Manufacturing Webinars

31. Cell Culture Solutions To Unlock Your Cell Performance 6/21/2024

    Gain insight into an innovative approach to cell culture media development, and learn about the journey a cell therapy company underwent to accelerate the development of their cell-based therapeutic.

32. Next-Gen Medium And Feeds System To Improve CHO Cell Line Productivity 6/19/2024

    Choose the right CHO medium and feed system to optimize your upstream processes and secure a seamless scaling up.

33. How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation 5/6/2024

    New technologies for the encapsulation of nucleic acids, such as FDmiX, can potentially overcome limitations of currently available standard mixing technologies.

34. Culturing And Characterizing Organoids And Cancer Spheroids 4/19/2024

    Discover techniques for generating, maintaining, and performing high-throughput analysis of organoids and other 3D culture systems that are essential for cutting-edge regenerative medicine research.

35. Optimizing Perfusion Parameters For Intensified Production Of CAR-T Cells 4/18/2024

    Achieving therapeutic doses in CAR-T cell therapies represents the longest phase of manufacturing. In this webinar, we explore scalable expansion processes designed to help meet growing demand.

36. Instant Implementation Of Raman-Based Monitoring 4/9/2024

    This platform, based on Raman technology with a de novo approach, operates as effortlessly as a pH-meter, providing real-time measurements of key process parameters such as glucose, lactate, and biomass.

37. Navigating Challenges In Immune Cell Therapy Analysis 3/27/2024

    During this panel, experts discuss the challenges faced by developers and manufacturers in the immune cell therapy field. These challenges include scalability, regulatory hurdles, and data standardization.

38. Enable Upstream Intensified Bioprocessing Using Modular Bioreactors 1/19/2024

    Discover a new technology that has been developed with flexibility, scalability across sizes, and an expanded design space to meet the increased performance needs of intensified bioprocesses.

39. Leveraging Stable Pool Material To Expedite The Path To IND 1/10/2024

    Review the efficacy of fast stable pools in generating purified product at an early stage, and learn how to accelerate the journey toward first-in-human trials and proof-of-concept studies.

40. Optimization-By-Design — A Critical Factor In Viral Vector Scale Up 12/14/2023

    Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.